Michael J. Lenardo
13Patents
6h-index
37Co-inventors
66Inventor score
Filing activity: Sep 15, 1993 → Jan 13, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6410516B1 | Nuclear factors associated with transcriptional regulation | Physics | 95 | Expired |
| US5804374A | Nuclear factors associates with transcriptional regulation | Physics | 46 | Expired |
| US6150090A | Nuclear factors associated with transcriptional regulation | Physics | 31 | Expired |
| US7148061B2 | Identification of a novel domain in the tumor necrosis factor receptor family that mediates pre-ligand receptor assembly and function | Chemistry; Metallurgy | 12 | Expired |
| US6083503A | Interleukin-2 stimulated T lymphocyte cell death for the treatment of autoimmune diseases, allergic responses, and graft rejection | Human Necessities | 10 | Expired |
| US5989546A | Interleukin-2 stimulated T lymphocyte cell death for the treatment of allergic responses | Human Necessities | 6 | Expired |
| US6312648A | Applicator system | Physics | 6 | Expired |
| US5935575A | Interleukin-4 stimulated T lymphocyte cell death for the treatment of allergic disorders | Emerging Cross-Sectional Technologies | 5 | Expired |
| US7838645B2 | Function of autophagy genes in cell death | Chemistry; Metallurgy | 1 | Expired |
| US10759838B2 | Myelin oligodendrocyte glycoprotein, myelin basic protein, and proteolipid protein compositions and methods of use | Chemistry; Metallurgy | 0 | Active |
| US12168802B2 | Methods of diagnosing and treating CD55 deficiency, hyperactivation of complement, angiopathic thrombosis and protein losing enteropathy (CHAPLE), a newly identified orphan disease | Chemistry; Metallurgy | 0 | Active |
| US7041503B2 | Modified myelin basic protein molecules | Emerging Cross-Sectional Technologies | 0 | Expired |
| US9051392B2 | Inhibitors of pre-ligand assembly doman and function of the tumor necrosis factor receptor family | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.